Notice |
How to write your comments onto a webpage
[2]
| 2016.07.06 | 운영자 | 2016.11.20 | 18193 |
Notice |
How to Upload Pictures in webpages
| 2016.07.06 | 운영자 | 2018.10.19 | 32347 |
Notice |
How to use Rich Text Editor
[3]
| 2016.06.28 | 운영자 | 2018.10.19 | 5924 |
Notice |
How to Write a Webpage
| 2016.06.28 | 운영자 | 2020.12.23 | 43840 |
2323 |
Are We Alone in the Universe?
[2] | 2019.10.19 | 이한중*65 | 2019.10.19 | 4244 |
2322 |
Walking Speed Equals Aging Speed Inversely
[4] | 2019.10.18 | 이한중*65 | 2019.10.19 | 50 |
2321 |
[LPGA] Kang Wins Second Consecutive Buick LPGA Shanghai
[3] | 2019.10.20 | 황규정*65 | 2019.10.21 | 98 |
2320 |
[Medical] Cequa, New Drug, For Dry Eye Diseae
[2] | 2019.10.20 | 이한중*65 | 2019.10.21 | 101 |
2319 |
신안군, 거문도, 백도
[5] | 2019.10.20 | 온기철*71 | 2019.10.22 | 203 |
» |
[Medical] Aducanumab, A Winner for Alzheimer's?
[1] | 2019.10.22 | 이한중*65 | 2019.10.22 | 40 |
2317 |
[WC] 한국축구, 북한과 평양 원정서 0-0 무승부, 조 1위 유지
[8] | 2019.10.14 | 황규정*65 | 2019.10.22 | 59 |
2316 |
[Medical] The Story of Childhood Statin Initiation
[7] | 2019.10.21 | 이한중*65 | 2019.10.23 | 84 |
2315 |
[Medical] Best Time To Take BP Meds
[1] | 2019.10.24 | 이한중*65 | 2019.10.24 | 79 |
2314 |
창경궁과 창경원, 종묘, 파고다 공원, 함춘원과 서울대학병원 유감
[4] | 2019.10.24 | 온기철*71 | 2019.10.27 | 137 |
2313 |
Tiger Woods takes 82nd PGA Tour title, tying Sam Snead atop list
[3] | 2019.10.27 | 황규정*65 | 2019.10.27 | 100 |
2312 |
가을의 모습들 그리고 음악/홍수웅
[1] | 2019.10.29 | 이한중*65 | 2019.10.29 | 62 |
2311 |
[LPGA] 장하나, BMW챔피언십 연장승부 끝 LPGA 통산 5승째
[2] | 2019.10.27 | 황규정*65 | 2019.10.29 | 48 |
2310 |
서울고: 서울역사박물관과 경희궁, 독립공원과 서대문형무소
[3] | 2019.10.29 | 온기철*71 | 2019.11.03 | 76 |
2309 |
강화도
[1] | 2019.11.02 | 온기철*71 | 2019.11.03 | 80 |
2308 |
하늘공원과 남이섬
[5] | 2019.10.30 | 온기철*71 | 2019.11.04 | 120 |
2307 |
남한에서 미군이 철수 한다면?
[1] | 2019.11.03 | 온기철*71 | 2019.11.04 | 65 |
2306 |
모든 정부는 거짓말을 한다
[4] | 2019.11.04 | 온기철*71 | 2019.11.06 | 113 |
2305 |
Questions Regarding Flu Shots Answered By CDC
[1] | 2019.11.06 | 이한중*65 | 2019.11.06 | 107 |
2304 |
[Medical] Seaweed Based Drug For Alzheimer's
[4] | 2019.11.04 | 이한중*65 | 2019.11.06 | 171 |
According to Biogen, this anti-amyloid, monoclonal antibody, Aducanumab
in the latest phase 3 trial turned out to be a winner for Alzheimer's as described in this article.
After discussing with FDA, Biogen is planning to apply for approval for the patients.
This agent will be the first such drug giving some hope for the patients.